First patients receive Lab-Grown immune cells in fight against leukemia
NCT ID NCT05987696
Summary
This early-stage study tested the safety of a new treatment using lab-grown natural killer (NK) immune cells in adults with acute myeloid leukemia (AML) that has returned or is hard to treat, or who have minimal traces of disease. The main goal was to see if the treatment was safe and what side effects it caused. Researchers also looked for early signs that it might help control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MINIMAL RESIDUAL DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institute of Hematology & Blood Diseases Hospital
Tianjin, China
Conditions
Explore the condition pages connected to this study.